Evaluation of bone disease in multiple myeloma: a comparison between the resorption markers urinary deoxypyridinoline/creatinine (DPD) and serum ICTP, and an evaluation of the DPD/osteocalcin and ICTP/osteocalcin ratios
Authors:
- 1 May 1999
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 62 (5) , 300-306
Abstract
Abstract: Markers of bone metabolism were measured in 73 newly diagnosed myeloma patients and in age‐matched controls. Correlations to bone disease on X‐rays and survival were performed. In urine deoxypyridinoline/creatinine (DPD) and in serum carboxyterminal pyridinoline cross‐linked telopeptide of type I collagen (ICTP), procollagen type I carboxy‐terminal extension peptide (PICP) and osteocalcin were analyzed. The ratios DPD/osteocalcin and ICTP/osteocalcin were calculated. Skeletal X‐ray findings were divided into no, limited and extensive bone involvement. DPD and ICTP levels were significantly elevated in patients compared to controls. Levels increased with advancing skeletal involvement. Serum osteocalcin was elevated in patients without visible bone disease. The level decreased with more advanced bone involvement. The finding of significantly elevated osteocalcin and ICTP levels in patients without bone involvement on X‐rays indicates that bone markers might reflect bone disease better than X‐rays in untreated myeloma patients. Ratios between bone resorption and bone formation markers added no further information on bone disease or survival. Only ICTP had prognostic value with an inverse correlation between serum levels and survival.Keywords
This publication has 19 references indexed in Scilit:
- Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double‐blind placebo‐controlled trialBritish Journal of Haematology, 1998
- Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy‐terminal telopeptide of type I collagen (ICTP)British Journal of Haematology, 1997
- Pyridinium cross-links in multiple myeloma: Correlation with clinical parameters and use for monitoring of intravenous clodronate therapy—A pilot study of the German Myeloma Treatment Group (GMTG)European Journal of Cancer, 1996
- Excessive bone resorption in human plasmacytomas: direct induction by tumour cells in vivoBritish Journal of Haematology, 1995
- Connective tissue components in serum in multiple myeloma: Analyses of propeptides of type I and type III procollagens, type I collagen telopeptide, and hyaluronanAmerican Journal of Hematology, 1994
- Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometryJournal of Bone and Mineral Research, 1993
- Biochemical Markers of Bone MetabolismAnnals of Medicine, 1993
- Serum osteocalcin concentrations in patients with multiple myeloma — correlation with disease stage and survivalJournal of Internal Medicine, 1992
- Allogeneic Bone Marrow Transplantation in Multiple MyelomaNew England Journal of Medicine, 1991
- Quantitative histology of myeloma‐induced bone changesBritish Journal of Haematology, 1982